| Descript |
xiii, 281 pages : illustrations ; 26 cm |
|
text txt rdacontent |
|
unmediated n rdamedia |
|
volume nc rdacarrier |
| Note |
Includes bibliographical references (pages 266-273) and index |
|
Foreword and acknowledgements -- The future of pharma : reprise -- Introduction and an invitation to skip a chapter -- An important industry at risk -- The best idea anyone has ever had -- The biologists got there first -- Applying evolutionary theory to the pharmaceutical and medical technology sectors -- Explaining the industry's past -- Predicting the future of pharma and medtech -- Practical implications for an evolving industry -- Watching the future unfold -- An immeasurably superior power -- Introduction: the emergent pressures of selection -- Selection pressures emerging from the social environment -- Selection pressures emerging from the technological environment -- Asking the right questions -- Evolution is cleverer than you are -- Introduction: Orgel's second law -- Technological innovator species emerging in the government payer habitat -- Technological innovator species emerging in patient payer habitats -- Operationally excellent species emerging in the government payer habitat -- Operationally excellent species emerging in patient payer habitats -- Customer intimate species emerging in the government payer habitat -- Customer intimate species emerging in patient payer habitats -- A big bang of life science business models -- Guiding the blind watchmaker -- Introduction: from description to prescription -- Which fitness peak(s) should we climb? -- What capabilities does our new business model need? -- How should we design a capable holobiont? -- How do we build our core capabilities? -- References -- Index |
| Subject |
Biotechnology industries
|
|
Business enterprises
|
|
